Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines …
WEBJun 15, 2023 · To better protect against the Omicron variant, which emerged in November 2021, ACIP recommended a dose of bivalent mRNA vaccine (containing mRNA encoding the spike protein from both the ancestral SARS-CoV-2 and Omicron BA.4/BA.5 SARS-CoV-2 variants) in September 2022 (2).
Effectiveness of Bivalent mRNA Vaccines in Preventing
WEBDec 1, 2022 · Bivalent mRNA booster doses provide additional protection against symptomatic SARS-CoV-2 in immunocompetent persons who previously received monovalent vaccine only, with relative benefits increasing with time since receipt of the most recent monovalent vaccine dose.
Effectiveness of Bivalent Boosters against Severe Omicron Infection
WEBJan 25, 2023 · Vaccine effectiveness against severe infection resulting in hospitalization or death was 24.9% (95% CI, 1.4 to 42.8) for one monovalent booster dose and 61.8% (95% CI, 48.2 to 71.8) for one...
WEBBivalent WT/Omicron BA.1 Vaccine 2-Dose Primary Series Compared to Prototype and Omicron BA.1 Monovalent Vaccine Candidate Vaccines administered at 0.5 mcg dose level at Days 0 and 21 to naïve mice
WEBJun 28, 2022 · In Naïve Individuals, Omicron Monovalent Vaccine Elicits a Predominantly Omicron-specific Response. 30 μg Dose, Evaluable Immunogenicity Population – Sentinel Group
WEBAug 22, 2024 · The information in this Fact Sheet about the Pfizer-BioNTech COVID-19 Vaccine, including information about the benefits, risks, and ingredients of that vaccine, also applies to your child’s...
WEBJan 25, 2023 · Vaccine effectiveness against severe infection resulting in hospitalization or death was 24.9% (95% CI, 1.4 to 42.8) for one monovalent booster dose and 61.8% (95% CI, 48.2 to 71.8) for one...
Bivalent Boosters against Severe Omicron Infection
WEBMay 3, 2023 · These results lead us to question the value of the Centers for Disease Control and Prevention policy to provide bivalent boosters to all persons 6 months of age or older 4 and prompt...
WEBEach 0.3 mL of the Pfizer-BioNTech Bivalent COVID-19 Vaccine, supplied in single dose and multiple dose vials with gray caps and gray label borders, is formulated to contain 15 mcg of a nucleoside-modified messenger RNA (modRNA) encoding the viral spike (S) glycoprotein of SARS-CoV-2 Wuhan-Hu-1 strain (Original) …
Pfizer and BioNTech Announce Updated Clinical Data for Omicron …
WEBNov 4, 2022 · Bivalent booster elicited approximately 4-fold higher neutralizing antibody titers against Omicron BA.4/BA.5 sublineages compared to the original COVID-19 vaccine in individuals older than 55 years of age.
Skip to content